Recurrence of venous thromboembolism in patients with familial thrombophilia

Archives of Internal Medicine

Volumn 157, Issue 19, 1997, Pages 2227-2232

  Van den Belt, Angelique G M ^a   Sanson, Bernd Jan ^b   Simioni, Paolo ^c   Prandoni, Paolo ^c   Büller, Harry R ^b   Girolami, Antonio ^c   Prins, Martin H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Institute of Medical Semeiotics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; PROTEIN C; PROTEIN S; WARFARIN;

ARTICLE; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; INCIDENCE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; PHLEBOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0030868686     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.19.2227     Document Type: Article

References (69)

1. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Haemost. 1965;13:516-523.
2. Hirsh J, Prins MH, Samama M. An approach to the thrombophilic patient. In: Colman RW, Hirsh J, Marder VL, Salzman EW, eds. Thrombosis and Haemostasis: Basic Principles and Practice. 3rd ed. Philadelphia, Pa: JB Lippincott; 1994:1543-1561.
3. van den Belt AGM, Huisman MV, Prins MH, Hirsh J. Familial thrombophilia: a review analysis. Clin Appl Hemostas Thromb. 1996;2:227-236.
4. Friederich PW, Scudeller A, Sanson B-J, et al. The incidence of venous thromboembolism and superficial vein thrombosis in ATIII-, protein S- and protein C-deficient subjects. Thromb Haemost. 1995;73:1262.
5. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briet E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet. 1993;341:134-138.
6. Levine MM, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108(suppl 4):276S-290S.
7. Aiach M, Gandrille S, Emmerich J. A review of mutations causing deficiencies of antithrombin, protein C and protein S. Thromb Haemost. 1995;74:81-89.
8. Van der Meer J, Stoepman-Van Dalen EA, Jansen JMS. Antithrombin-3 deficiency in a Dutch family. J Clin Pathol. 1973;26:532-536.
9. Scully MF, De Hass H, Chan P, Kakkar W. Hereditary antithrombin III deficiency in an English family. Br J Haematol. 1981;47:235-241.
10. Thuot C, Marion D, Boucher H. Deficit congenital en antithrombine m étude d'une famille Quebecosie. Union Med Can. 1977;106:673-677.
11. Sas G, Peto I, Banhegyi D, Blasko G, Domjan G. Heterogeneity of the 'classical' antithrombin III deficiency. Thromb Haemost. 1980;43:133-137.
12. Leone G, Valori VM, Storti S, Myers TJ. Inferior vena cava thrombosis in a child with familial antithrombin III deficiency. Thromb Haemost. 1980;43:74-79.
13. Ambruso DR, Jacobson LJ, Hathaway WE. Inherited antithrombin III deficiency and cerebral thrombosis in a child. Pediatrics. 1980;65:125-132.
14. Marciniak E, Farley GH, DeSimone PA. Familial thrombosis due to antithrombin deficiency. Blood. 1974;43:219-225.
15. Rey JL, Delobel J, Claisse JF, Quiret JC, Bor P, Bernasconi P. Embolie pulmonaire severe et thrombophlebite recidivante en rapport avec un deficit hereditaire en antithrombine III. Arch Mal Coeur Vaiss. 1979;72:919-925.
16. Juillet Y, Vayssairat M, Fiessinger JN, Aiach M, Housset E. Thrombose des veines portes et mesenterique superieure au cours d'un deficit congenital et familial en antithrombine III. Ann Intern Med. 1979;130:53-58.
17. Griffith MJ, Carraway T, White GC, Dombrose FA. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma. Blood. 1983;61:111-116.
18. Brenner B, Fishman A, Goldsher D, Schreibman D, Tavory S. Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol. 1988;27:209-212.
19. Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE. Abnormal antithrombin III defective serine protease binding (antithrombin III 'Denver'). J Clin Invest. 1986;77:887-891.
20. Lane DA, Erdjument H, Flynn A, et al. Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis. Br J Haematol. 1989;71:91-96.
21. 384 - Pro mutation with abnormal thrombin-binding activity and thrombotic diathesis. Thromb Res. 1990;59:793-798.
22. Aiach M, Roncato M, Chaduef G, Dezellus P, Capron L, Fiessinger JN. Antithrombin III Avranches, a new variant with defective serine-protease inhibition: comparison with antithrombin III Charleville. Thromb Haemost 1988;60:94-98.
23. Girolami A, Marafioti F, Rubertelli M, Vicarioto MA, Cappellato G, Mazzuccato M. Antithrombin III Trento: a new congential AT III abnormality with a peculiar crossed immunoelectrophoretic pattern in absence of heparin. Acta Haematol. 1984;72:73-78.
24. Bessot J-C, Ouoix E, Charbonneau J, et al. Deficit hereditaire en anti-thrombine III responsable d'accidents thrombo-emboliques recidivants. Nouv Presse Med. 1978;7:999-1003.
25. Tengborn L, Frohm B, Nilsson L-E, Nilsson IM. A Swedish family with abnormal antithrombin III. Scand J Haematol. 1985;34:412-416.
26. Aiach M, Nora M, Fiessinger J-N, et al. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville. Thromb Res. 1985;39:559-561.
27. Barbui T, Finazzi G, Rodeghiero F, Dini E. Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza'). Br J Haematol. 1983;54:561-564.
28. Matsuo T, Ohki Y, Kondo S, Matsuo O. Familial antithrombin III deficiency in a Japanese family. Thromb Res. 1979;16:815-822.
29. Beukes CA, Heyns ADP. A South African family with antithrombin III deficiency. S Afr Med J. 1980;58:528-533.
30. Carivalho A, Ellman L. Hereditary antithrombin III deficiency: effect of antithrombin III deficiency on platelet function. Am J Med. 1976;61:179-182.
31. Gyde OHB, Middleton MD, Vaughan GR, Fletcher DJ. Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses. BMJ. 1978;1:621-623.
32. Zucker ML, Gomperts ED, Marcus RG. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency. S Afr Med J. 1976;50:1743-1745.
33. Tripodi A, Boyer C, Canciani MT, D'Angelo A, Mannucci PM. Inherited deficiency of antithrombin III in an Italian kindred. Ricerca Clin Lab. 1980;10:521-525.
34. Winter JH, Fench A, Ridley W, et al. Familial antithrombin III deficiency. Q J Med. 1982;51:373-376.
35. Cosgriff TM, Bishop DT, Hershgold EJ, et al. Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine. 1983;62:209-213.
36. Odegard OR, Abildgaard U. Antifactor Xa activity in thrombophilia: studies in a family with AT-III deficiency. Scand J Haematol. 1977;18:86-90.
37. Stathakis NE, Papayannis AG, Antonopoulos M, Gardikas C. Familial thrombosis due to antithrombin III deficiency in a Greek family. Acta Haematol. 1977;57:47-51.
38. Manotti C, Quintavalla R, Megha A, Ponari O, Dettori AG. Inherited deficiency of antithrombin III in two Italian families. Haemostasis. 1982;12:300-305.
39. Johansson L, Hedner U, Nilsson IM. Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis. Acta Med Scand. 1978;204:491-493.
40. Howarth DJ, Samson D, Stirling Y, Seghatchian MJ. Antithrombin III 'Northwick Park': a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity. Thromb Haemost. 1985;53:314-317.
41. Leone G, De Stefano V, Di Donfrancesco A, Ferrelli R, Traisci G, Bizzi B. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern. Br J Haematol. 1987;65:187-191.
42. Lane DA, Lowe GDO, Flynn A, Thompson E, Ireland H, Erdjument H. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. Br J Haematol. 1987;66:523-525.
43. Sorensen PJ, Dyerberg J, Stoffersen E, Krogh Jensen M. Familial functional antithrombin III deficiency. Scand J Haematol. 1980;24:105-109.
44. Davous P, Horellou MH, Conard J, Samama M. Cerebral infarction and familial protein S deficiency. Stroke. 1990;21:1760-1764.
45. Mannucci PM, Tripodi A, Bertina RM. Protein S deficiency associated with 'juvenile' arterial and venous thromboses. Thromb Haemost. 1986;55:440-445.
46. Allaart CF, Aronson DC, Ruys TH, et al. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost. 1990;64:206-209.
47. Boyer-Neumann C, Wolf M, Amiral J, Guyader A-M, Meyer D, Larrieu JJ. Familial type 1 protein S deficiency associated with severe venous thrombosis: a study of five cases. Thromb Haemost. 1986;60:1298-1302.
48. Coller BS, Owen J, Jesty J, et al. Deficiency of plasma protein S, protein C or antithrombin III and arterial thrombosis. Arteriosclerosis. 1987;7:456-461.
49. Girolami A, Simioni P, Lazzaro AR, Cordiano I. Severe arterial cerebral thrombosis in patients with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thromb Haemost. 1989;61:144-145.
50. Kamiya T, Sugihara T, Ogata K, et al. Inherited deficiency of protein S in a Japanese family with recurrent venous thrombosis: a study of three generations. Blood. 1986;67:406-408.
51. Engesser L, Broekmans AW, Briët EE, Brommer EJP, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med. 1987;106:677-682.
52. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood. 1984;64:1297-1300.
53. Comp PC, Esmon C. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984;311:1525-1528.
54. Girolami A, Simioni P, Lazzaro AR, Pontara E, Ruzza G. Heterozygous protein S deficiency: a study of a large kindred. Acta Haematol. 1990;84:162-168.
55. Michiels JJ, Bertina RM, Broekmans AW, Engesser L, van Vliet HHDM. Een familie met veneuze trombose en erfelijke proteine S-deficiëntie. Ned Tijdschr Geneeskd. 1987;131:1043-1047.
56. Vogel VG, Machulik M, Lauten G. Thrombophilie infolge eines protein-C-defektes vom typ II. Z Gesamte Inn Med. 1987;42:550-557.
57. Kemkes-Matthes B. Heterozygous protein C deficiency type I. Blut. 1989;58:201-204.
58. Broekmans AW, Bertina RM. Protein C. In: Broekmans AW, ed. Recent Advances in Blood Coagulation. New York, NY: Churchill Livingstone Inc: 1985:117.
59. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood. 1989;73:712-715.
60. Pabinger-Fasching I, Bertina RM, Lechner K, Niessner H, Kornigerner C. Protein C deficiency in two Austrian families. Thromb Haemost 1983;50:810-813.
61. Griffin JH, Evatt B, Zimmerman TS, Neiss AJ. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981;68:1370-1374.
62. Melissari E, Kakkar W. Congenital severe protein C deficiency in adults. Br J Haematol. 1989;72:222-226.
63. Broekmans AW, Velkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism: a study in three Dutch families. N Engl J Med. 1983;309:340-344.
64. Zauber NP, Kudryk AB. Protein deficiency in three generations of one family. N J Med. 1988;85:805-809.
65. Bauer GA. A venographic study of thromboembolism problems. Acta Chir Scand. 1940;84(suppl 61):1-75.
66. Haeger K. Problems of acute deep venous thrombosis, I: the interpretation of signs and symptoms. Angiology. 1969;20:219-223.
67. Hull R, Delmore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med. 1979;301:855-858.
68. Brandjes DPM, Herjboer H, Büller HR, et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1992;327:1485-1489.
69. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute venous thrombosis. Ann Intern Med. 1996;125:1-7.